HG
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Prognostic and therapeutic considerations of antibodies against c‐ter apolipoprotein A‐1 in the general population | Clinical & translational immunology |  | 2020 | 209 | 166 | ||
| High-affinity binding of chemokine analogs that display ligand bias at the HIV-1 coreceptor CCR5 | Biophysical Journal | | 2019 | 314 | 206 | ||
| Characterisation of preproendothelin-1 derived peptides identifies Endothelin-Like Domain Peptide as a modulator of Endothelin-1 | Scientific Reports | | 2017 | 450 | 289 | ||
| Generating Chemokine Analogs with Enhanced Pharmacological Properties Using Phage Display | Methods in enzymology |  | 2016 | 574 | 5 | ||
| A scalable low-cost cGMP process for clinical grade production of the HIV inhibitor 5P12-RANTES in Pichia pastoris | Protein expression and purification | | 2016 | 586 | 333 | ||
| Enhancing Antitumor Immune Responses by Optimized Combinations of Cell-penetrating Peptide-based Vaccines and Adjuvants | Molecular therapy | | 2016 | 684 | 395 | ||
| The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease? | PloS one | | 2015 | 563 | 387 | ||
| δ-Conotoxins synthesized using an acid-cleavable solubility tag approach reveal key structural determinants for NaV subtype selectivity | The Journal of biological chemistry | | 2014 | 677 | 1 | ||
| Definition of human apolipoprotein A-I epitopes recognized by autoantibodies present in patients with cardiovascular diseases | The Journal of biological chemistry | | 2014 | 769 | 658 | ||
| A novel µ-conopeptide, CnIIIC, exerts potent and preferential inhibition of NaV1.2/1.4 channels and blocks neuronal nicotinic acetylcholine receptors | British journal of pharmacology | | 2012 | 739 | 0 | ||
| Alteration of synaptic network dynamics by the intellectual disability protein PAK3 | The Journal of neuroscience |  | 2012 | 716 | 0 | ||
| Efficient orthogonal bioconjugation of dendrimers for synthesis of bioactive nanoparticles | Bioconjugate chemistry | | 2011 | 657 | 0 | ||
| CC chemokine receptor 5 (CCR5) desensitization: cycling receptors accumulate in the trans-Golgi network | The Journal of biological chemistry | | 2010 | 663 | 63 | ||
| Highly potent HIV inhibition: engineering a key anti-HIV structure from PSC-RANTES into MIP-1 beta/CCL4 | Protein engineering, design & selection | | 2008 | 678 | 8 | ||
| Semisynthetic analogues of PSC-RANTES, a potent anti-HIV protein | Bioconjugate chemistry | | 2008 | 716 | 5 | ||
| Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide | Proceedings of the National Academy of Sciences of the United States of America | | 2008 | 622 | 2 | ||
| Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors | Proceedings of the National Academy of Sciences of the United States of America | | 2004 | 717 | 1 | ||
| Industrial-scale proteomics: from liters of plasma to chemically synthesized proteins | Proteomics | | 2004 | 635 | 0 | ||
| Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines | Journal of virology | | 2003 | 559 | 387 |
